GLP1R and metabolic dysfunction-associated steatohepatitis: In liver tissue, the expression of GLP-1 receptors is controversial [117], but Svegliati-Baroni was able to demonstrate that, in human livers of subjects with NASH, both the expression and protein content of GLP-1R were decreased compared to subjects without NASH [128].